Strongest Psychedelic Known to Man Now Being Used in Clinical Trials
The world’s first regulated clinical trial of DMT clears the way for Earth’s most powerful psychoactive drug to join the psychedelic therapy revolution.
DMT, or N, N-Dimethyltryptamine, is a highly potent hallucinogen that naturally occurs in many plant species, including in one of the plant ingredients of ayahuasca. It can also be synthetically produced in a laboratory.
DMT is known for inducing intense metaphysical trips, which are reportedly similar to near-death experiences. Having been used underground in the west for decades, it is now attracting the interest of pharmaceutical companies and scientists looking to investigate its potential mental health benefits.
Jay Waxenberg is the director of the DMTx program at the Center for Medicinal Mindfulness. Based in Boulder, CO, it was one of the first centers to offer legal psychedelic therapy in the U.S.
“DMT is actually the most powerful psychedelic on Earth that we’re aware of, and what makes it special and different from other psychedelics is that it’s endogenous, which means it’s produced within our own bodies. It’s also produced in nearly every ecosystem on Earth — it’s everywhere, it’s all around us – which is also kind of leading to what is really unique about it, the extent of a DMT experience, it’s at most 20 minutes,” Waxenberg said.
While there is a wide range of phenomena experienced during a DMT trip, there are some fascinating common hallmarks.
“This alternate reality experience, or this experience that people will call ‘realer than real.’ It’s a reality similar to our own, but completely different,” Waxenberg said. “Some of the elements within that would be the entity encounters, which is very common for people; intense geometric, hyperbolic shapes; and out-of-body, traveling to the center of the universe; ego-dissolution, ego death; these are really common experiences under it.”
While advocates have been reporting profound healing benefits for decades, there have not been any clinical studies on DMT due to its status as a Schedule 1 controlled substance, until now.
Canadian pharmaceutical company small pharma recently completed the first clinical trial of DMT-assisted therapy. The trial was Phase 1, meaning it established the safety and feasibility of studying the psychedelic in this way.
Small pharma is now moving into Phase 2 trials involving patients with Major Depressive Disorder. Practitioners like Waxenberg have high hopes that the studies will bear out DMT’s great potential for addressing psychological issues.
“If somebody has an ego death, or somebody leaves their body, there’s this feeling of expansiveness that comes with that; a feeling of not feeling trapped in your life. So, if you’re in depression, or anxiety, or thought-loop patterns, or anything like this, often that’s the benefit — to break yourself out of those cycles, to break yourself out of those loops or thought patterns. In the dying process, people who are getting terminal diagnoses, that’s where the most benefit can come because it’s an instantaneous removal of the ego and out of your body to go into that space; experiences that take them right into what they believe the afterlife process will be or what they believe the death process will be — and really watching that be nourishing and supportive of, ‘Ok, this is maybe something I can actually go toward,’” Waxenberg said.
“Also, it’s going to have really big benefits toward treatment-resistant depression. Like ketamine, it’s this out-of-body experience that alone can help reset the nervous system, reset what your baseline is of happiness or wellness, it can get totally reset just like that.”
Many in the psychedelic therapy world will be watching closely for the results of the coming DMT-assisted therapy trials.
“My hope is to just keep opening the door wider and wider, as we bring more and more people into the space, more and more people into the conversation to see what these substances can do. And really within this meta-crisis, we find ourselves in culturally, I think DMT is an answer to a lot of those questions; how can we really see a different angle to the problems that we face?”
New Gene Discovery May Explain Rapid Human Brain Evolution
A revealing new study on human evolution and brain development has just been published. Could this lend credence to the stoned ape theory of brain evolution?
About 300,000-800,000 years ago the human brain experienced a massive and accelerated growth spurt. Scientists have offered many explanations for how and why this may have occurred, but a new study out of Boston Children’s Hospital focused on a fast-evolving set of the human genome called human accelerated regions (HARS). Previous studies have found about 3,100 HARS during brain development, but the team at Children’s Hospital determined one HAR gene PPP1R17 could be responsible for or play a significant role in, rapid brain development. Further, they discovered this works differently in humans than in other animals.
Ben Stewart, the host of Gaia’s Limitless series, said,”[T]hese regions of the human DNA may hold some kind of an answer at the rapid explosion of human neo-cortex because if you think of it evolutionarily, there’s not been one creature, at least on planet Earth, that has been studied that had any organ increase in size as large and as rapidly as the human brain did, so there’s definitely some unanswered questions there.”
“I’m pretty sure that these HARS regions are being looked at for something very unique in the evolution of the brain, and my own personal twist on it is this also might be important when we start looking at brian-machine interfaces and how the brain can potentially cause mutations to adapt to some kind of technology in the brain to enhance or evolve the human brain,” Stewart said.
How could this new discovery be related to the Stoned Ape theory?
“There’s a possibility that the Stoned Ape theory could lead into this. Now, the Stoned Ape theory was really popularized by Terence McKenna,” Stewart said. “Over time, you would have some of our ancient ancestors, hominids, that would be following behind bovine creatures, cows, and in the cow patties in the fields that would naturally, having followed these creatures around for hundreds of thousands of years or whatever it might have been, that they would have started eating the mushrooms, the psilocybin mushrooms that grow naturally in cow patties. These experiences tickling the language centers and other parts of the brain, bringing down the rigidity of the default mode network, and activating other communication hubs within the brain, that could actually explain the rapid explosion of the human neocortex.”
“In this article, they’re saying that these human accelerated regions act differently in humans than they do in primates or creatures like mice and ferrets that they’ve looked into now. So, potentially if there is some connection with the Stoned Ape theory, that psychedelics or psychotropics helped in the expansion of the human neocortex, and made us as, at least psychologically, so much different than the rest of the creatures on Earth, then there may be something to look at here.”
